Glyceryl Trinitrate — supply status, manufacturers & alternatives

Glyceryl Trinitrate

—

🇦🇺 AUST R 301499 · Medicianz Healthcare Pty Ltd

In supply · Australia

Nitrong Tts

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

🇦🇺 AUAEMPA$11.75DPMQ A$38.88details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Glyceryl Trinitrate

Therapeutic category	Auto-created by National Organisation for Medicines — Drug Shortages scraper

Controlled substance	No

Marketing-authorisation holders	Medicianz Healthcare Pty Ltd, Sanofi-Aventis Australia Pty Ltd, iNova Pharmaceuticals Australia Pty Ltd, ACCORD-UK LIMITED +10 more

Registrations on file	21

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$11.75

AEMP

Dispensed (DPMQ)

A$38.88

incl. fees

Pack

glyceryl trinitrate 400 microgram/actuation spray, 200 actuations

Source: PBSEffective July 2026 · AUD

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 12 resolved events

◷

0–5 months

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

2 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

High concentration risk

Dipharma Francis SrlDynamit Nobel GMBH Explosivstoff Und Systemtechnik

Manufacturing countries: Italy, Germany · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🌐

IMA · 18h ago

Resolved

🇬🇷

EOF · 1mo ago

Resolved

Verified timeline regulator events

🌐 16 May 2026

Shortage resolved

🌐 13 May 2026

Shortage resolved

🌐 2 May 2026

Shortage resolved

🇬🇷 27 Apr 2026

Shortage resolved

🌐 3 Apr 2026

Shortage resolved

🌐 4 Feb 2026

Shortage resolved

Sources official regulators

🌐

IMA

verified 18h ago

verify ↗

🇬🇷

EOF

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders21 registrations · 14 MA holders

Product	Strength	Form	Market	MA holder	Status
Wkt	50 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active
NITROLINGUAL PUMPSPRAY glyceryl trinitrate	400mcg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
Minitran	5 g	—	🇦🇺 AU	iNova Pharmaceuticals Australia Pty Ltd	Active
Minitran	10 g	—	🇦🇺 AU	iNova Pharmaceuticals Australia Pty Ltd	Active
Minitran	15 g	—	🇦🇺 AU	iNova Pharmaceuticals Australia Pty Ltd	Active
Glyceryl Trinitrate Tablets Bp	500MCG	tablet	🇬🇧 GB	ACCORD-UK LIMITED	Active
Glyceryl Trinitrate Tablets Bp	600 MICROGRAM	tablet	🇬🇧 GB	ACCORD-UK LIMITED	Active
GLYCERYL TRINITRATE 1MG/ML SOLUTION FOR INFUSION	1MG	solution	🇬🇧 GB	HAMELN PHARMA LTD	Active
GLYCERYL TRINITRATE 300 MICROGRAMS TABLETS	300 MICROGRAM	tablet	🇬🇧 GB	MACARTHYS LABORATORIES LIMITED	Active
GLYCERYL TRINITRATE 5MG/ML STERILE CONCENTRATE	5MG	glyceryl	🇬🇧 GB	Hospira UK Limited	Active
Glyceryl Trinitrate Tablets Bp	0.5MG	tablet	🇬🇧 GB	BRISTOL LABORATORIES LIMITED	Active
Glyceryl Trinitrate Tablets Bp	0.6MG	tablet	🇬🇧 GB	BRISTOL LABORATORIES LIMITED	Active
GLYCERYL TRINITRATE 400 MICROGRAMS/METERED DOSE, SUBLINGUAL SPRAY	400 MICROGRAM	spray	🇬🇧 GB	EGIS PHARMACEUTICALS UK LIMITED	Active
Glyceryl Trinitrate Spray	400 MICROGRAM	spray	🇬🇧 GB	EVOLAN PHARMA AB	Active
Glyceryl Trinitrate Macure	1 MG	solution	🇬🇧 GB	MACURE PHARMA UK LIMITED	Active

+6 more registrations on file

Mederti Drug Report

Generated 3 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.